Moreover, GITR levels were significantly decreased compared to HCs in a cohort study of 136 individuals investigating immune checkpoint regulator (ICs) levels in patients with CHB-related liver cirrhosis [75]. This evidence concerns the gene TNFRSF18 and cirrhosis of liver.